1. |
朱曉峰,陳規劃.乙肝患者肝移植后乙肝復發的防治 [J]. 肝膽外科雜志, 2000; 8(3)∶191.
|
2. |
Angus PW. Review: hepatitis B and liver transplantation [J]. J Gastroenterol Hepatol, 1997; 12(3)∶217.
|
3. |
袁育紅,胡品津.乙型肝炎病毒感染與肝移植 [J]. 國外醫學內科學分冊, 1999; 26(6)∶235.
|
4. |
Samuel D, Feray C, Bismuth H. Hepatitis viruses and liver transplantation [J]. J Gastroenterol Hepatol, 1997; 12(9-10)∶S335.
|
5. |
賈繼東,王寶恩.肝移植術后乙肝復發的預防和治療 [J]. 中華肝臟病雜志, 2002; 10(1)∶61.
|
6. |
Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen [J]. N Engl J Med, 1993; 329(25)∶1842.
|
7. |
劉勇,嚴律南.乙型肝炎相關肝臟疾病肝移植術后乙肝復發的預防 [J]. 外科理論與實踐, 2002; 7(2)∶171.
|
8. |
Samuel D, Bismuth A, Mathieu D, et al. Passive immunoprophylaxis after liver transplantation in HBsAgpositive patients [J]. Lancet, 1991; 337(8745)∶813.
|
9. |
肖春云.干擾素治療慢性病毒性肝炎的研究現狀 [J]. 醫學綜述, 1998; 4(11)∶590.
|
10. |
陳規劃,何曉順. 70例原位肝移植 [J]. 中華外科雜志, 2001;39(3):679.
|
11. |
王建設. 拉咪呋啶對慢性乙型肝炎治療的突破及面臨問題 [J]. 臨床肝病雜志, 2000; 16(3)∶134.
|
12. |
李必海. 拉咪呋啶對慢性乙型肝炎的治療作用 [J]. 國外醫學藥學分冊, 2000; 27(2)∶102.
|
13. |
朱建平,張月琳.肝移植術后乙型肝炎病毒再感染的防治 [J]. 中華器官移植雜志, 2003; 24(2)∶28.
|
14. |
鄭樹森,吳健.肝移植患者乙型肝炎病毒再感染的防治 [J]. 中華器官移植雜志, 2000; 21(6)∶366.
|
15. |
Malkan G, Cattral MS, Humar A, et al. Lamivudine for hepatitis B in liver transplantation: a singlecenter experience [J]. Transplantation, 2000; 69(7)∶1403.
|
16. |
陸堅. 核苷類似物治療慢性乙型肝炎臨床研究進展 [J]. 醫學綜述, 1998; 4(6)∶320.
|
17. |
Manns MP. Famcidovir treatment of hepatitis B infection follwing liver transplantation: a longterm, multicentre study [J]. Transplant Inject Dis, 2001; 3(1)∶16.
|
18. |
Han SH, Kinkhabwala M, Martin P, et al. Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir [J]. Am J Gastroenterol, 1998; 93(11)∶2245.
|
19. |
Rayes N, Seehofer D, Hopf U, et al. Comparison of famciclovir and lamivudine in the long term treatment of hepatitis B infection after liver transplantation [J]. Transplantation, 2001; 71(1)∶96.
|
20. |
Balzarini J, Hao Z, Herdewijn P, et al. Intracellular metabolism and mechanism of antiretrovirus action of 9(2phosphonylmethoxyethyl)adenine, a potent antihuman immunodeficiency virus compound [J]. Proc Natl Acad Sci USA, 1991; 88(4)∶1499.
|
21. |
黃硯青,龔作炯.阿地福韋體外抗乙肝病毒的活性 [J]. 中國醫院藥學雜志, 2001; 21(11)∶656.
|
22. |
Heijtink RA, De Wilde GA, Kruining J, et al. Inhibitory effect of 9(2phosphonylmethoxyethyl)adenine (PMEA) on human and duck hepatitis B virus infection [J]. Antiviral Res, 1993; 21(2)∶141.
|
23. |
成軍.阿地福韋在慢性乙型肝炎治療中的應用 [J]. 國外醫學病毒學分冊, 2001; 8(3)∶85.
|
24. |
成軍. 拉米夫定在肝移植患者乙型肝炎病毒再感染防治與治療中的應用第36屆歐洲肝病年會巡禮 [J]. 國外醫學病毒學分冊, 2001; 8(6)∶185.
|
25. |
Perrillo R, Schiff E, Yoshida E, et al. Adefovir dipivoxil for the treatment of lamivudineresistant hepatitis B mutants [J]. Hepatology, 2000; 32(1)∶129.
|
26. |
嚴律南.肝臟良性疾病的肝移植 [J]. 中國普外基礎與臨床雜志, 2003; 10(4)∶321.
|
27. |
江正輝,王槐志. 拉米夫定在肝移植中的應用情況 [J]. 胃腸病學和肝臟病學雜志, 2002; 11(3)∶ 278.
|